Hepatitis B: Issues in laboratory diagnosis and vaccination

Australian Prescriber

Volumn 21, Issue 3, 1998, Pages 72-75

  Siebert, David ^a   Locarnini, Stephen ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Immunity; Liver disease; Vaccines

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; RECOMBINANT VACCINE; VIRUS DNA;

CHRONIC HEPATITIS; DENTISTRY; DRUG RESPONSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; INTRAMUSCULAR DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; REVACCINATION; REVIEW; VACCINATION; VIRUS MORPHOLOGY;

EID: 0031658380     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.1998.069     Document Type: Article

References (5)

1. Gust ID. Control of hepatitis B in Australia. The case for alternative strategies. Med J Aust 1992;156:819-21.
2. National Health and Medical Research Council. Hepatitis B. In: The Australian Immunisation Handbook. 6th ed. Canberra: Australian Government Publishing Service, 1997:109-20.
3. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993;342:1335-40.
4. Tilzey AJ. Hepatitis B vaccine boosting: the debate continues. Lancet 1995;345:1000-1.
5. Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. Br Med J 1997;314:329-33.